Press Releases on December 6, 2018 - EIN Presswire - Press Release Distribution Service

Published on December 6, 2018 - 13:15 GMT

Recent Analysis Shows Microsoft, Alnylam Pharmaceuticals, F5 Networks, Green Plains Partners LP, Itron, and Progress Software ...

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Microsoft Corporation (NASDAQ:MSFT …

Distribution channels: Banking, Finance & Investment Industry

Published on December 6, 2018 - 13:15 GMT

H&R Block Announces Fiscal 2019 Second Quarter Results; Introducing Upfront, Transparent Pricing and Virtual Tax Innovations for ...

KANSAS CITY, Mo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) today released its financial results for the fiscal 2019 second quarter ended October 31, 2018. The company normally reports a fiscal second quarter loss due to the …

Distribution channels: Banking, Finance & Investment Industry ...

Published on December 6, 2018 - 13:11 GMT

IsoEnergy Ltd. Announces C$4.5 Million Bought Deal Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 06, 2018 (GLOBE NEWSWIRE) -- IsoEnergy Ltd. (TSXV:ISO) (“IsoEnergy” or the “Company”) is pleased to announce …

Distribution channels: Banking, Finance & Investment Industry

Published on December 6, 2018 - 13:10 GMT

Recent Analysis Shows Athenex, National CineMedia, Macy's, Manulife Financial, CBS, and Strategic Education Market Influences — ...

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Athenex, Inc. (NASDAQ:ATNX), …

Distribution channels: Banking, Finance & Investment Industry

Published on December 6, 2018 - 13:07 GMT

Blowing Agents Market Global Size, Share, Trends and Forecast 2026: Acumen Research and Consulting

Blowing Agents Market (By Foam Type - Polyurethane Foam, Phenolic Foam, Polystyrene Foam; Market By Product Type - Hydrofluorocarbons (HFCs), Hydrochlorofluorocarbons (HCFCs), Hydrocarbons (HCs); Market By Application - Building and Construction, …

Distribution channels: Banking, Finance & Investment Industry

Published on December 6, 2018 - 13:05 GMT

Global Vehicle License Plate Market Analysis & Forecast (2018-2022): The Increasing Amount of Vehicle Registrations Year-on-Year ...

Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The "Global Vehicle License Plate Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. One trend in the market is growing popularity of RFID-based license plate. RFID tags are …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on December 6, 2018 - 13:05 GMT

Proofpoint Named a Leader in 2018 Gartner Magic Quadrant for Enterprise Information Archiving for Seventh Consecutive Year

SUNNYVALE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Proofpoint, Inc., (NASDAQ: PFPT), a leading cybersecurity and compliance company, today announced it has been positioned by Gartner, Inc. in the Leaders quadrant of the 2018 Magic Quadrant for Enterprise …

Distribution channels: IT Industry ...

Published on December 6, 2018 - 13:05 GMT

GT Biopharma Presents Positive Preclinical Data of Tri-specific NK Cell Engager (TriKE) at the 60th American Society of Hematology ...

– Company’s proprietary TriKE product candidates have the potential to serve as a relatively safe, cost-effective, and easy-to-use therapy for refractory/relapsed AML, high-risk MDS and advanced systemic mastocytosis – – Positive preclinical findings …

Distribution channels:

Published on December 6, 2018 - 13:05 GMT

Organovo Appoints New Board Member

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2018 - 13:05 GMT

Cocoa Butter Market is likely to exceed the Valuation of US$ 8.9 Billion towards 2028 End- Future Market Insights

VALLEY COTTAGE, N.Y., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Cocoa butter is a stable fat that is obtained by pressing cacao beans. Cocoa butter is white in color, soft in texture and has the flavor and aroma of cocoa. Cocoa butter is responsible for imparting …

Distribution channels: Banking, Finance & Investment Industry ...

Published on December 6, 2018 - 13:03 GMT

Novo Announces Results of 2018 Annual General Meeting

VANCOUVER, B.C., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that its Annual General Meeting of shareholders was held in Vancouver, British Columbia, Canada on December …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...

Published on December 6, 2018 - 13:03 GMT

Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan

Updated Phase 2 Results in Metastatic Triple-Negative Breast Cancer to be Presented at The 2018 San Antonio Breast Cancer Symposium (SABCS) Continue to Show Meaningful Clinical Benefit Consistent with Prior Results Pivotal Randomized Study in Hormone …

Distribution channels: Technology ...

Published on December 6, 2018 - 13:01 GMT

Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations

PLANO, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation (SCS) system has been implanted in over 3,000 patients in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2018 - 13:01 GMT

Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in ...

-- Single pivotal Phase 3 trial design, using once-daily dosing, may be sufficient for approval of OV101 in Angelman syndrome -- -- Trial initiation activities have begun for ELARA, an open-label extension study for patients with Angelman syndrome who …

Distribution channels: Technology ...